{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:57:16Z","timestamp":1794301036665,"version":"4.9.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.vaccine.2007.01.119","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T14:28:35Z","timestamp":1172154515000},"page":"3816-3826","source":"Crossref","is-referenced-by-count":345,"title":["Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies"],"prefix":"10.1016","volume":"25","author":[{"given":"George R.","family":"Siber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherryl","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Fernsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathuram","family":"Santosham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith P.","family":"Klugman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Paradiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kohberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.01.119_bib1","first-page":"283","article-title":"Methods for estimating serological correlates of protection","volume":"89","author":"Siber","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2007.01.119_bib2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/171.6.1387","article-title":"Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum","volume":"171","author":"Robbins","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.01.119_bib3","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"Jodar","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.01.119_bib4","unstructured":"WHO, (2005) Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Technical Report Series. No. 927."},{"key":"10.1016\/j.vaccine.2007.01.119_bib5","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/315323","article-title":"Correlates of immune protection induced by live, attenuated, cold adapted, trivalent, intranasal influenza virus vaccine","volume":"181","author":"Belshe","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.01.119_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.01.119_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomized trial","volume":"362","author":"O\u2019Brien","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.01.119_bib8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9 valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.01.119_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal polysaccharide enzyme linked immunosorbent assay","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.01.119_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease. Part I. Implications for conjugate vaccine formulation and use","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2007.01.119_bib11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CDLI.2.5.590-597.1995","article-title":"Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S","volume":"2","author":"Quataert","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.01.119_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/CDLI.10.4.514-519.2003","article-title":"Enzyme linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides","volume":"10","author":"Wernette","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.01.119_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00006454-199909000-00004","article-title":"Safety and immunogenicity of heptavalent pneumococcal CRM 197 conjugate vaccine in infants and toddlers","volume":"18","author":"Shinefield","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.01.119_bib14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/00006454-200211000-00006","article-title":"Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa","volume":"21","author":"Huebner","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.01.119_bib15","doi-asserted-by":"crossref","unstructured":"O\u2019Brien KL, Moisi J, Moulton LH, Madore DV, Eick A, Reid R, et al. Predictors of conjugate pneumococcal vaccine immunogenicity among infants and toddlers in the American Indian PnCRM 7 efficacy trial. J Infect Dis 2007; in press.","DOI":"10.1086\/518438"},{"key":"10.1016\/j.vaccine.2007.01.119_bib16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double-blind, placebo-controlled trial","volume":"356","author":"Cutts","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.01.119_bib17","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case control study","volume":"368","author":"Whitney","year":"2006","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2007.01.119_bib18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/CVI.13.3.356-360.2006","article-title":"Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera","author":"Henckaerts","year":"2006","journal-title":"Clin Vaccine Immunol Mar"},{"key":"10.1016\/j.vaccine.2007.01.119_bib19","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/S0264-410X(98)00475-7","article-title":"IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines","volume":"17","author":"Soininen","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.01.119_bib20","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/S0264-410X(98)00458-7","article-title":"Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood","volume":"17","author":"Anttila","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.01.119_bib21","first-page":"353","article-title":"Anti-C- carbohydrate antibodies after pneumococcal vaccination","volume":"90","author":"Pedersen","year":"1982","journal-title":"Acta Path Microbiol Immunol Scand Sect C 1982"},{"key":"10.1016\/j.vaccine.2007.01.119_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1128\/CDLI.7.3.468-476.2000","article-title":"Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?","volume":"7","author":"Soininen","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.01.119_bib23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/368200","article-title":"Immunogenic Protein Contaminants in Pneumococcal Vaccines","volume":"187","author":"Yu","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.01.119_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00193394","article-title":"Induction of antipneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates","volume":"181","author":"Peeters","year":"1992","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2007.01.119_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/mpat.1997.0175","article-title":"Periodate oxidation of R36A pneumococci greatly enhances production of hybridomas secreting anti protein antibodies","volume":"24","author":"Casal","year":"1998","journal-title":"Microb Pathog"},{"issue":"2","key":"10.1016\/j.vaccine.2007.01.119_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0264-410X(96)00148-X","article-title":"The synthesis of Streptococcus pneumoniae polysaccharide tetanus toxoid conjugates and the effect of chain length on immunogenicity","volume":"15","author":"Laferriere","year":"1997","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.01.119_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.inf.0000160942.84169.14","article-title":"Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children","volume":"24","author":"Madhi","year":"2004","journal-title":"Ped lnf Dis J"},{"key":"10.1016\/j.vaccine.2007.01.119_bib28","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1016\/j.vaccine.2005.07.038","article-title":"Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children","volume":"23","author":"Madhi","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.01.119_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/422531","article-title":"Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media","volume":"190","author":"Jokinen","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.01.119_bib30","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1086\/431679","article-title":"Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus","volume":"192","author":"Dagan","year":"2005","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07001569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07001569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T05:46:30Z","timestamp":1587361590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07001569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":30,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0264410X07001569"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.01.119","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}